Literature DB >> 14769388

The presence of astrocytes in areas of demyelination influences remyelination following transplantation of oligodendrocyte progenitors.

William F Blakemore1, Jennifer M Gilson, A John Crang.   

Abstract

To date, most experiments examining the myelination potential of transplanted cells have been undertaken into either the immature nervous system or into acutely demyelinating lesions. Since these are situations where myelination or remyelination are occurring, such studies provide little information on the likely outcome of introducing myelinogenic cells into area of chronic demyelination. In an attempt to gain a greater understanding of the interaction between astrocytes and oligodendrocyte progenitors in areas of demyelination, we undertook transplantation experiments in which an identical preparation of oligodendrocyte progenitors (OPCs) was (1) transplanted directly into astrocyte-free areas of acute demyelination (3 days after induction), (2) transplanted cranial to similar areas of demyelination (20 days after induction) or (3) transplanted cranial to areas of demyelination (20 days after induction) that had been injected with astrocytes at 3 days to confront OPCs with demyelinated axons in an astrocytic environment. The acute astrocyte-free lesions were remyelinated by oligodendrocytes and Schwann cells while the delayed interaction of OPCs with demyelinating lesions resulted in only oligodendrocyte remyelination, the extent of which was reduced when the area of demyelination contained astrocytes. The results of these experiments illustrate that the introduction of OPCs into an astrocyte-free area of demyelination soon after its induction favours Schwann cell differentiation while the presence of established astrocytes in an area of demyelination has an inhibitory effect on the extent of oligodendrocyte remyelination achieved by OPCs.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14769388     DOI: 10.1016/S0014-4886(03)00347-9

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  27 in total

Review 1.  Engineering Stem Cells for Biomedical Applications.

Authors:  Perry T Yin; Edward Han; Ki-Bum Lee
Journal:  Adv Healthc Mater       Date:  2015-03-13       Impact factor: 9.933

2.  Grafts of brain-derived neurotrophic factor and neurotrophin 3-transduced primate Schwann cells lead to functional recovery of the demyelinated mouse spinal cord.

Authors:  Christelle Girard; Alexis-Pierre Bemelmans; Noëlle Dufour; Jacques Mallet; Corinne Bachelin; Brahim Nait-Oumesmar; Anne Baron-Van Evercooren; François Lachapelle
Journal:  J Neurosci       Date:  2005-08-31       Impact factor: 6.167

Review 3.  Connexins-mediated glia networking impacts myelination and remyelination in the central nervous system.

Authors:  Tao Li; Christian Giaume; Lan Xiao
Journal:  Mol Neurobiol       Date:  2014-01-07       Impact factor: 5.590

4.  Schwann cell-like differentiation by adult oligodendrocyte precursor cells following engraftment into the demyelinated spinal cord is BMP-dependent.

Authors:  Jason F Talbott; Qilin Cao; Gaby U Enzmann; Richard L Benton; Virginie Achim; Xiao X Cheng; Michael D Mills; Mahendra S Rao; Scott R Whittemore
Journal:  Glia       Date:  2006-08-15       Impact factor: 7.452

5.  S100B as a Potential Biomarker and Therapeutic Target in Multiple Sclerosis.

Authors:  Andreia Barateiro; Vera Afonso; Gisela Santos; João José Cerqueira; Dora Brites; Jack van Horssen; Adelaide Fernandes
Journal:  Mol Neurobiol       Date:  2015-07-17       Impact factor: 5.590

6.  Astrocytes from the contused spinal cord inhibit oligodendrocyte differentiation of adult oligodendrocyte precursor cells by increasing the expression of bone morphogenetic proteins.

Authors:  Yaping Wang; Xiaoxin Cheng; Qian He; Yiyan Zheng; Dong H Kim; Scott R Whittemore; Qilin L Cao
Journal:  J Neurosci       Date:  2011-04-20       Impact factor: 6.167

7.  Astrocytic tissue inhibitor of metalloproteinase-1 (TIMP-1) promotes oligodendrocyte differentiation and enhances CNS myelination.

Authors:  Craig S Moore; Richard Milner; Akiko Nishiyama; Ricardo F Frausto; David R Serwanski; Roberto R Pagarigan; J Lindsay Whitton; Robert H Miller; Stephen J Crocker
Journal:  J Neurosci       Date:  2011-04-20       Impact factor: 6.167

8.  Growth factor regulation of remyelination: behind the growing interest in endogenous cell repair of the CNS.

Authors:  Regina C Armstrong
Journal:  Future Neurol       Date:  2007-11

9.  Early loss of oligodendrocytes in human and experimental neuromyelitis optica lesions.

Authors:  Claudia Wrzos; Anne Winkler; Imke Metz; Dieter M Kayser; Dietmar R Thal; Christiane Wegner; Wolfgang Brück; Stefan Nessler; Jeffrey L Bennett; Christine Stadelmann
Journal:  Acta Neuropathol       Date:  2013-11-30       Impact factor: 17.088

Review 10.  White matter astrocytes in health and disease.

Authors:  I Lundgaard; M J Osório; B T Kress; S Sanggaard; M Nedergaard
Journal:  Neuroscience       Date:  2013-11-11       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.